Global Inflatable Tents Market Projected to Reach US$ 1,496 Million by 2028, Driven by Strong 7.5% CAGR

The global inflatable tents market is positioned for substantial growth, with a projected year-on-year increase of 7.5%, poised to culminate in a market valuation of approximately US$ 1,496.0 million by the close of 2028. This positive outlook stems from various key factors, with the vibrant expansion of the tourism industry notably driving heightened demand within the camping sector. Moreover, the confluence of escalating per capita income levels and a growing inclination toward investing in top-tier camping gear is anticipated to further propel the sales of inflatable tents.

A primary catalyst behind the escalating demand for inflatable tents is the robust growth of the tourism sector. As an increasing number of individuals seek adventure and outdoor experiences, camping emerges as a preferred choice for travelers. In response to this trend, the camping gear market, inclusive of inflatable tents, is witnessing notable growth as campers actively seek innovative and convenient solutions to elevate their outdoor escapades.

Take The First Step – Request Your Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-7105 

Future Market Insights (FMI) is set to provide a comprehensive analysis and review of the dynamic factors shaping the inflatable tent market. This assessment will encompass a range of industry-specific influences and key perspectives driving innovation within the sector.

The tourism industry, currently experiencing rapid growth, is poised to be a pivotal driver in the increased sales of inflatable tents. Furthermore, the combination of rising per capita income and a growing willingness among consumers to invest in camping gear is expected to further propel the market for inflatable tents.

Country-wise Insights: Rising Demand for Inflatable Tents

United States: A Surge in Military Activity and Outdoor Enthusiasm

The United States has witnessed a consistent increase in military spending, solidifying its position as the world’s top military spender. This expenditure extends to deployable military shelters and the establishment of new military camps globally. Simultaneously, a strong inclination towards camping and trekking activities among the American populace is stoking the demand for inflatable tents. In 2022, the U.S. Inflatable Tents Market is poised to register an impressive 7.5% year-on-year growth in terms of volume, underscoring the nation’s enthusiasm for outdoor adventures.

Germany: Leading the Way in Western Europe

Germany, a prominent tourism destination in Western Europe, is set to maintain its stature as one of Europe’s premier markets for inflatable tents. The rise in outdoor camping activities within Germany is creating lucrative opportunities for the sales of inflatable tents. Projections indicate that Germany will continue to dominate the Western Europe inflatable tents market throughout the forecast period (up to 2028), with a robust 7.9% Volume Compound Annual Growth Rate (CAGR).

China: Thriving Camping Culture and Manufacturing Capacity

Camping has gained immense popularity in Asia-Pacific countries, with China emerging as a prominent player in this trend. The growth of tourism in China, driven by factors such as a burgeoning youth population, robust economic growth, increasing disposable incomes, and rapid urbanization, has led to a surge in demand for inflatable tents. China boasts significant manufacturing capacity for inflatable tents and has witnessed remarkable growth in its military sector. Consequently, China is poised to capture a substantial share of the global inflatable tents market. The demand for inflatable tents in China is projected to experience a commendable Compound Annual Growth Rate (CAGR) of 7.3%.

Key Players:

  • Lanco Group
  • Kampa AG
  • Oase Outdoors ApS (Outwell)
  • AMG Group Ltd
  • Zempire Camping Equipment
  • Heimplanet
  • Losberger GmbH
  • Coleman Company, Inc.
  • Exxel Outdoors, LLC (Kelty)
  • Sports Direct International (Gelert)
  • skandika GmbH
  • Sunncamp Limited

Don’t Wait – Buy Your Premium Report Now! https://www.futuremarketinsights.com/checkout/7105 

Global Inflatable Tents Market by Category:

By Material Type:

  • PVC
  • Poly-Cotton
  • Nylon

By Type:

  • Self-Erecting
  • Hybrid

By Shape:

  • Dome
  • Tunnel
  • Geodesic

By End Use:

  • Military
  • Commercial
  • Personal

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • MEA
  • APEJ
  • Japan

Craft Your Analysis – Request A Customized Report Now! https://www.futuremarketinsights.com/customization-available/rep-gb-7105

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

RevOps Platform Market Surges: Global Size Reaches US$ 3,652.3 Million in 2023, Poised for $18,062.6 Million by 2033

The global revenue operations (RevOps) platform market size is estimated to be valued at US$ 3,652.5 million in 2023 and is projected to surpass a valuation of US$ 18,062.6 million by 2033. The demand for revenue operations (RevOps) platform is likely to rise at a CAGR of 17.3% from 2023 to 2033.

The RevOps (Revenue Operations) platform market refers to the market for software solutions and tools that allow companies to improve and streamline their revenue generation operations. Marketing, sales, and customer success functions are frequently integrated into RevOps systems, allowing organizations to unify their revenue-generating people, processes, and technologies.

Enterprises are coming to understand the value of integrating their revenue-generating processes and investing in RevOps systems. These systems offer a centralized framework for controlling and optimizing revenue processes, leading to improved productivity, increased revenue, and happier clients. The increased adoption of RevOps systems is expected to boost market demand.

Request a Sample of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15481

The RevOps platform market is experiencing consolidation with larger players acquiring smaller vendors to expand their range of offerings. This blend is driving innovation and the creation of more extensive and fuller of features RevOps systems.  Consolidation in the RevOps platform industry allows entities to provide end-to-end revenue operations solutions. Companies can deliver a more streamlined and thorough experience to their clients by merging many tools and capabilities into a single platform. The market is therefore anticipated to experience a rapid surge during the forecast period.

Key Takeaways

  • The expansion in North America can be attributed to the presence of many established players offering advanced revenue operations platform solutions and services. The market in the United States held a share of 17.4% in 2023.
  • As per FMI’s research China is estimated to record an incremental CAGR of 14.5% in the forecast period
  • Europe accounted for 19.8% in 2022 of the global market. The IT sector in Europe is rapidly expanding, thereby leading to the adoption of RevOps platform solutions.
  • India’s RevOps Platform Market is expected to rise with a CAGR of 19.6% during the projected period. This significant value is accredited to the developing technological enhancement and significant investment by key players in these emerging economies.

Competitive Landscape

Some of the prominent players operating in the RevOps platform market are

  • Go Nimbly
  • Openprise Inc.
  • Clari Inc.
  • ai Inc.
  • io
  • LeanData Inc.
  • Full cast
  • RightRev
  • Humanlinker
  • Sales panel
  • io

Businesses are increasingly prioritizing customer success and retention as critical revenue drivers and vendors are constantly enhancing their solutions to meet the evolving needs of businesses, leading to a competitive and dynamic market landscape.

Request for Methodology:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15481

Recent Developments

  • Go Nimbly, a global leader, has been in business for more than 10 years and has been scaling high growth SaaS companies and fueling sales for them. Go Nimbly ‘s RevOps Accelerator, an instructor-led program to win a Revenue Operations strategy was organized in July 2023 and is planned for the same in September 2023.
  • Openprise in May 2023 introduced RevOps Data Automation Solutions for Microsoft Dynamics 365 along with an enhanced solution for attribution powered by the Openprise RevOps Data Automation (RDA) Cloud.

RevOps Platform Market Outlook by Category

By Solution:

  • RevOps Platform
  • Cloud-Based
  • On-premises
  • Services
  • Professional Services
  • Consulting
  • Integration & Deployment
  • Support & Maintenance
  • Managed Services

By Enterprise Size:

  • Small and Medium-sized Enterprises (SMEs)
  • Large Enterprises

By Industry:

  • BFSI
  • Healthcare
  • Retail
  • IT and Telecom
  • Manufacturing
  • Government
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East and Africa (MEA)

Request for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-15481

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Corporate Event Planner Market Poised for Robust Growth at a Staggering CAGR of 31.8% through 2033

Based on projections, the Corporate Event Planner Market is expected to expand at a Compound Annual Growth Rate (CAGR) of 31.8% from 2023 to 2033. The market is anticipated to reach a valuation of US$ 390.7 billion in 2023 and rise to a remarkable US$ 6,196.4 billion market share by 2033.

The growing need for automation in event management firms is the reason for this noteworthy growth in the corporate event planner market. Automation is quickly becoming more and more popular as a way to simplify event operations and provide ease and efficiency when planning business gatherings.

Furthermore, there is a growing emphasis on deriving actionable insights from corporate events, which is driving key trends and opportunities within the corporate event planning industry. Event planners are increasingly harnessing data and analytics to optimize event outcomes and enhance attendee experiences.

Unlock Precious Insights: Download Our Sample Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15473

Market Snapshot

  • Projected CAGR of 31.8% between 2023 and 2033.
  • Market expected to be valued at US$ 390.7 billion in 2023.
  • Anticipated market share of US$ 6,196.4 billion by 2033.
  • Increasing demand for automation to simplify event functionalities.

Drivers and Opportunities

The Corporate Event Planner Market’s robust growth is driven by the following factors:

  1. Automation in Event Management: Companies are adopting automation solutions to streamline event planning, execution, and post-event analysis.
  2. Actionable Insights: Event planners are focusing on extracting valuable insights from events to enhance decision-making and improve future events.

Competitive Landscape – Regional Trends

The corporate event planning industry is experiencing regional variations in terms of market dynamics. Different regions are witnessing varying adoption rates of automation and data-driven event planning.

Unlock Strategic Knowledge: Get Instant Access to Our Detailed Report.
https://www.futuremarketinsights.com/checkout/15473

Key Players 

  • Bassett Events, Inc.
  • MKG
  • Colin Cowie
  • David Tutera
  • JR Global Events
  • Rafanelli Events
  • Oren Co
  • Wonderland
  • Event Solutions
  • MGM Resorts
  • AJ Williams Events

Region-wise Insights

  • North America: Leading the market in terms of automation adoption, with a focus on data-driven event planning.
  • Europe: Witnessing steady growth in corporate event planning, with an increasing emphasis on actionable insights.
  • Asia-Pacific: Emerging as a lucrative market, driven by the adoption of automation and the growing demand for corporate events.
  • Latin America: Experiencing a surge in corporate events, creating opportunities for event planners to offer innovative solutions.
  • Middle East and Africa: Seeing gradual growth in the corporate event planning sector, with potential for future expansion.

Category-wise Insights

  • Technology-driven Events: Witnessing rapid growth as companies leverage technology for immersive experiences.
  • Sustainable Events: A rising trend as environmental concerns drive sustainable event planning practices.
  • Hybrid Events: Gaining traction as a blend of in-person and virtual experiences becomes more popular.

Request for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-15473

Key Segments Covered

By Event Type:

  • Conference/Seminar
  • Trade Shows/Exhibitions
  • Incentive Programs
  • Company Meetings
  • Others

By Industry Type:

  • Banking and Financial Sector
  • Information Technology
  • Real Estate and Infrastructure
  • Automotive
  • Insurance
  • Others

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

 

Global Super Generics Industry Expected to Reach US$413 Billion by 2033, Driven by 7.2% CAGR | FMI

The Global Super Generics Industry is expected to reach a market value of US$413 billion by 2033, representing unparalleled growth. According to Future Market Insights Inc.’s most recent study, this amazing increase is being driven by a promising compound annual growth rate (CAGR) of 7.2% from 2023 to 2033.

As of 2023, the market generates a solid revenue of US$ 205 billion, demonstrating the sector’s stability and the potential for substantial developments and possibilities in the next years.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4126

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic era to focus on the growth and development of the Global Super Generics Industry. The study features insights into the current growth dynamics and the major revenue reforms prevailing in the market along with the key takeaways from the forecast.

The team of analysts at Future Market Insights is focussing on research and market study to produce different Global Super Generics Industry forecasts and predictions at both national and international levels. They have considered several leads of information about the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Super Generics Market.

Global Super Generics Industry Key Players

The writer will create content on the general strategies of market players. And then will write the key players in the market are: Sun Pharmaceutical Industries Ltd., Meda Pharmaceuticals Inc., Taiwan Liposome Company, Dr. Reddy’s Laboratories Ltd., Allergan plc., Teva Pharmaceutical Industries Ltd., and Celgene Corporation

Global Super Generics IndustrySegmentation

The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion of the market. Numerous segmentations have been provided for this market based on:

Exploring the study’s key assumptions. Ask An Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-4126

Based on the product type, the Global Super Generics Industry is segmented into the following:

  • Drugs
  • Biologics

Based on the route of administration, the Global Super Generics Industry is segmented into the following:

  • Oral
  • Injectable
  • Topical
  • Others

Based on the distribution channel, the Global Super Generics Industry is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

Product Segmentation

The investigation offers a top-to-bottom evaluation of different clients’ journeys pertinent to the market and its segments. The study endeavors to assess the current and future development possibilities, undiscovered roads, and factors that shape their income potential in the global market by breaking it into di such as its types, applications, and region-wise assessment.

Full in-depth analysis of the parent market

The analysts at FMI are dedicated to providing insights after extensive research and study. The study also includes estimations, projections, and evaluation of the market dynamics.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/4126

Important changes in market dynamics

The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.

Segmentation details of the market

  • Former, ongoing, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Histology and Cytology Consumables Industry is expected to grow at a rapid rate of 10.2% CAGR between 2023 and 2033, reaching US$ 22,833 Million | FMI

The Global Histology and Cytology Consumables Industry is expected to reach US$ 8,637.6 million by 2023, representing unparalleled growth. The sector is expected to grow at a compound annual growth rate (CAGR) of 10.2% between 2023 and 2033, making it a beacon of innovation and technical improvement.

Future Market Insights Inc.’s thorough study, based on rigorous market analysis undertaken by specialists, emphasizes the sector’s potential to accomplish significant milestones over the next decade. The report digs into the drivers behind this tremendous development, offering valuable insights to industry stakeholders, investors, and decision-makers.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4096

An increase in the prevalence of cell-based diseases like cancer and autoimmune diseases necessitates the detection and diagnosis of specific cells and tissues, an increase in healthcare spending, an increase in the number of hospitals and diagnostic laboratories, an increase in the demand for personalised medicines, an increase in the study of individual cell structure and function, and an increase in the number of hospitals and diagnostic laboratories.

Moreover, the demand for histology and cytology consumables will increase shortly due to technical developments in the detection and treatment of infectious diseases as well as developments in molecular techniques.

Why Choose Future Market Insights?

  • Serving domestic and international clients 24/7
  • Prompt and efficient customer service
  • Data collected from reliable primary and secondary sources
  • Highly trained and experienced team of research analysts
  • Seamless delivery of tailor-made market research reports

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-4096

Global Histology and Cytology Consumables Industry: Segmentation

To simplify the gargantuan study, the report is segregated based on different segments.

By product Type:

  • Kits and Reagents
  • Enzymes
  • Stains and dyes
  • Others

By End User:

  • Hospital
  • Diagnostic Centers
  • Biotechnology and Pharmaceutical Industry
  • Academic Research Institutes
  • Others

By Region:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, and the Rest of Latin America)
  • Western Europe (Germany, Italy, France, UK, Spain, Nordic countries, Belgium, Netherlands, Luxembourg, and Rest of Western Europe)
  • Eastern Europe (Poland, Russia and Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, and Rest of MEA)

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-4096

The aforementioned segments are studied concerning each individual region, considering the region-specific trends, drivers and restraints.

Global Histology and Cytology Consumables Industry: Competition Analysis

The study bestows valuable insights into the competitive landscape of the Global Histology and Cytology Consumables Industry, by studying numerous players, their growth strategies, and key developments. The report dwells deep and studies different facets such as product launches, production methodologies, and steps adopted by players to make processes cost-effective, among others, are expected to influence their individual standpoint. Understanding the prevailing trends and strategies on the supply side empowers players to foster their plan of action accordingly to progress on a remunerative path. Key players covered in the research include

  • Thermo Fisher Scientific, Inc.,
  • Danaher Corporation,
  • Abbott Laboratories,
  • Becton Dickinson and Company,
  • F. Hoffmann-La Roche Ltd,
  • Promega Corporation,
  • Agilent Technologies Inc.,
  • Roche Holding AG,
  • Merck KGaA,
  • Allergan, Plc,
  • PerkinElmer, Inc.
  • Others

Key Questions Answered in FMI’s Global Histology and Cytology Consumables Industry Report

  1. Which region is anticipated to hold a prominent market share over the forecast period?
  2. What will be the key driving factor propelling the demand for Histology And Cytology Consumables Supplies during the forecast period?
  3. How current socio-economic trends will impact the Histology And Cytology Consumables Supplies market?
  4. What are the growth strategies implemented by prominent players in the Histology And Cytology Consumables Supplies market to maintain their foothold in the competitive landscape?

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Aquaculture Therapeutics Industry is expected to grow robustly at an 8.6% CAGR and reach US$ 3.98 Billion By 2033 | According to FMI

Future Market Insights Inc. (FMI), a leading industry analyst, has released a projection that shows a promising future for the Global Aquaculture Therapeutics Industry. They anticipate a remarkable Compound Annual Growth Rate (CAGR) of 8.6% from 2023 to 2033. Thanks to this ground-breaking discovery, the industry is now recognized as a major participant in the worldwide market thanks to forecasts indicating a successful path towards a market share of US$ 3.98 billion by 2033.

The market for aquaculture treatments is expected to develop steadily and sustainably over the next ten years, with a trend that indicates significant growth. Based on thorough research conducted by FMI, the sector is predicted to hit a major milestone in 2023, with a market value of US$ 1.74 billion.

Global Aquaculture Therapeutics Industry: Drivers and Restraints

A lot of advances are taking place in the aquaculture therapeutics as there are several diseases which are affecting the animals cultured in the aquaculture. There are several diseases which are driving the aquaculture therapeutics market. Mostly the diseases are dependent on hygiene conditions which are to be maintained. Advances in aquaculture therapeutics, and growing demand for the more effective aquaculture therapeutic drugs are the factors expected to drive the growth of aquaculture therapeutics market. More over the demand for aquaculture is growing day by day due to the decreasing number of the oceanic fishes and increasing consumption of the fishes at a global level.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2463

The Farming or the culturing of aquatic animals like the fishes, algae, mollusks, crustaceans, aquatic plants and other aquatic organisms in different types of water is termed as Aquaculture. The cultivation process involves nurturing of these aquatic organism in the controlled condition either in fresh or in salt water. Later on these aquatic organisms are then harvested to be served as the source of nutrition or to be used for many other purposes.

The aquatic animals are very sensitive and are prone to various epidemic diseases. Other factors affecting the aquatic cultured animals are Pathogens (e.g. bacteria, viruses, fungi and parasites) exist in all natural water bodies. At the same time crowded culture environment makes the causes high risk for infection and makes the fishes nervous. Crowding also results in fish knocking eventually leading to surface wounds which is a cause for inaction.

These can be cured using several FDA approved antibiotics and other medicines. Apart from diseases medicines are used to improve the wellbeing of the fishes in the aquaculture. The list of drugs includes chorionic gonadotropin, formalin solution, florfenicol, oxytetracycline, tricaine methane sulfonate, hydrogen peroxide, sulfadimethoxine/ormetoprim combination, acetic acid, calcium chloride, calcium oxide, carbon dioxide gas, fuller’s earth, garlic (whole form), ice, magnesium sulfate, papain, potassium chloride, povidone iodine, sodium bicarbonate, sodium chloride, sodium sulfite, thiamine hydrochloride, urea and tannic acid.

The above mentioned drugs take care of the aquatic animals fighting with several diseases which are not only harmful to the aquatic animals but are also harmful to the consumer. There are two different categories of diseases which affect the aquatic population viz. diseases due to pathogens which are indigenous to the local environment and exotic pathogens.

Global Aquaculture Therapeutics Industry: Overview

Despite the long tradition of practicing aquaculture in several countries it is still a growing and a business with great scope. The requirement of aquaculture therapeutics is increasing day by day as more and more countries have stared adopting aquaculture which is cheaper source of protein. As the fishes or the animals are consumed by the human FDA has set up certain regulatory guidelines for the drugs to be administered to the fishes in aquaculture. They are categorized as conditionally approved animal drugs and indexed animal drugs. Depending upon environmental and diseased conditions these drugs are used in the aquatic fishes.

Aquaculture Therapeutics Industry: Regional Overview

Region-wise, the global Aquaculture therapeutics market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. China is the leading in the aquaculture market which contributes around 61% of the global aquaculture market which is followed by Indonesia and India.

Discovering the assumptions behind the study. Ask An Analyst Now!
https://www.futuremarketinsights.com/ask-question/rep-gb-2463

Global Aquaculture Therapeutics Industry: Key Players

Some of the key players in the Global Aquaculture Therapeutics Industry are

  • TunaTech GmbH,
  • ViAqua Therapeutics Ltd,
  • Alpharma, Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

The report covers an exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/2463

Global Aquaculture Therapeutics Industry: Segmentation

The global Aquaculture therapeutics market has been classified based on product type, end user and geography.

Based on product type, the Global Aquaculture Therapeutics Industry is divided into following:

  • Chorionic Gonadotropin
  • Formalin Solution
  • Florfenicol
  • Oxytetracycline
  • Tricaine Methane Sulfonate
  • Hydrogen Peroxide
  • Sulfadimethoxine/Ormetoprim combination

Based on the end user type, the Global Aquaculture Therapeutics Industry is divided into the following:

  • Veterinary Pharmacies
  • E commerce
  • Veterinary Clinics
  • Veterinary Hospitals

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Veterinary Auto-Immune Therapeutics Industry is expected to grow at a 5.3% CAGR and reach US$ 71.7 Billion by 2033 | FMI

As Future Market Insights (FMI) projects an astounding valuation of US$ 71,720.6 million for the Global Veterinary Auto-Immune Therapeutics Industry by 2033, the veterinary healthcare sector is poised for a revolutionary shift. This forecast is a significant increase from the US$ 42,815.7 million that was reported in 2023, exhibiting an exceptional compound annual growth rate (CAGR) of 5.3% from 2023 to 2033.

FMI adopted a multidisciplinary strategy to guide the expansion and advancement of the global veterinary auto-immune therapeutics industry in the face of the difficulties presented by the pandemic. The thorough analysis offers significant insights into the market’s major revenue changes and current growth patterns as of 2020, providing important takeaways that will remain relevant for the duration of the forecast period.

The rise in the use of veterinary auto-immune medicines underscores a global trend towards innovative methods for treating animal auto-immune illnesses. This includes the development of novel medications, as well as the integration of diverse therapies such as surgeries and stem cell treatments.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2462

Impact of COVID-19 on the Healthcare Industry

The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years.

The team of analysts at Future Business Insights are focussing on research and market study to produce different Animal Auto-immune Disease Therapeutics Market forecasts and predictions at both national and international levels. They have considered several leads of information about the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Animal Auto-immune Disease Therapeutics Market.

Ask Us Your Questions About This Report
https://www.futuremarketinsights.com/ask-question/rep-gb-2462

Global Veterinary Auto-Immune Therapeutics Industry Key Players 

Some of the key players in the global Animal Auto-immune Disease Therapeutics Market are Aratana Therapeutics Inc., Pfizer Inc., Vet-Stem, Inc., Ambrx Inc., Taconic Biosciences, Inc., JBS United, Virbac, Eli Lilly and Company, Jaguar Animal Health Inc. and many more.

Segmentation 

Key Segments Profiled In The Global Veterinary Auto-Immune Therapeutics Industry Survey

By Therapy Type:

  • Corticosteroids, Azathioprine
  • Cyclosporine
  • Mycophenolate
  • Leflunomide
  • Cyclophosphamide
  • Levothyroxine
  • Folic Acid
  • Hydroxychloroquine
  • Chloroquiney

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-2462

By Disease Indication:

  • Hypothyroidism
  • Pemphigus Disease
  • Canine Lupus
  • Auto-Immune Hemolytic Anemia
  • Bullous Pemphigoid
  • Discoid Lupus Erythematosus (DLE)
  • Immune-related arthritis
  • Others

By Animal Type:

  • Companion Animal
  • Dogs
  • Cats
  • Horse
  • Live Stock Animal
  • Cattle
  • Swine
  • Poultry
  • Fish
  • Sheep

By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics

By Region:

  • North America
  • Latin America
  • The Asia Pacific
  • Middle East and Africa
  • Europe

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/2462

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Angiographic Catheters Industry is expected to grow at a 4.3% annual rate and surpass US$2.2 Billion by 2033 | FMI

According to Future Market Insights (FMI) most recent prediction, the Global Angiographic Catheters Industry is expected to reach a notable valuation of US$ 2,215.4 million by 2033, following a dynamic trajectory suggestive of robust industry progress. This estimate is a significant rise over the US$ 1,451.0 million 2023 valuation, demonstrating an outstanding Compound Annual Growth Rate (CAGR) of 4.3%.

Angiographic catheters have drawn the attention of major market players due to their acknowledged critical role in the accurate administration of therapeutic drugs and radiopaque media inside the circulatory system. These catheters are extremely important since they play a crucial role in directing guide wires to precise target areas, especially when treating cardiac conditions.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-6053

Global Angiographic Catheters Industry: Drivers and Restraints

The increasing prevalence of cardiac vascular diseases (CVDs) and the increased demand for precise diagnostic and procedural equipment in the worldwide healthcare sector are driving up demand for Angiographic Catheters, resulting in the global Angiographic Catheters industry expanding. Furthermore, the ageing population and lifestyle changes that induce hypertension, obesity, and other risk factors for vascular disorders are expected to fuel market growth for Angiographic Catheters.

The high cost of angiographic procedures and other components, on the other hand, may hamper the global Angiographic Catheters industry’s growth. Furthermore, the availability of alternative therapies, as well as the problems associated with Angiographic Catheters, may hamper the growth of the global Angiographic Catheters industry.

Global Angiographic Catheters Industry: Overview

The global market for Angiographic Catheters is expected to grow considerably over the forecast period due to the increasing popularity of angiographic treatments. An angiographic catheter is a surgically invasive, short-term device. The device is designed to detect cardiac defects or problems with the central circulation system.

External factors such as the rising use of e-commerce and logistics services in developing and underdeveloped countries are also propelling the growth of the angiographic catheter market. The global market for Angiographic Catheters is classified into two categories: scoring balloon catheters and cutting balloon catheters. Based on end users, the market is split into hospitals, ambulatory surgery centers, specialized clinics, and others. The hospital segment accounts for the majority of the market for Angiographic Catheters.

Ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-6053

Angiographic Catheters Industry: Regional Outlook

Geographically, the global Angiographic Catheters industry is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate the global Angiographic Catheters industry over the forecast period due to the increasing incidences of cardiovascular diseases in this region.

Western Europe is expected to be the second largest market for Angiographic Catheters due to the increasing government support for people undergoing coronary angioplasty through reimbursement thus increasing the adoption of angioplasty catheters in the region. Asia Pacific market is expected to experience delayed growth due to unawareness of the use of Angiographic Catheters and low disposable income.

Global Angiographic Catheters Industry: Key Players

Some of the players identified in the global Angiographic Catheters industry include AngioDynamics, Inc., Terumo Europe NV, Medtronic, Merit Medical Systems, Inc., OSCOR Inc., B. Braun Melsungen AG, Cardinal Health, InSitu Technologies Inc., BVM Medical Limited, Precision Extrusion Inc., Cardiva, C. R. Bard, Inc., Boston Scientific Corporation and others. In recent years, manufacturers have improved the surface properties of Angiographic Catheters.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, applications, and industries.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition and companies involved
  • Technology
  • Value Chain

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/6053

Global Angiographic Catheters Industry: Segmentation

Tentatively, the global Angiographic Catheters industry has been segmented based on product type, end-user, and geography.

Based on product type, Global Angiographic Catheters Industry is segmented as below:

  • Scoring balloon catheters
  • Cutting balloon catheters

Based on end-user, Global Angiographic Catheters Industry is segmented as below:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty clinics
  • Others

Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Retractable Needle Safety Syringes Industry is expected to grow at a steady 4.1% CAGR, with a target valuation of US$ 8,770 Million by 2033 | FMI

The Global Retractable Needle Safety Syringes Industry is expected to reach US$ 5,846.6 million by 2023, indicating significant growth. According to industry analysts, this rising trend is likely to continue, with a Compound Annual Growth Rate (CAGR) of 4.1% forecast from 2023 to 2033. By the end of this decade-long trip, the market is expected to reach an amazing US$ 8,770 million.

This expected rise demonstrates the critical role that Retractable Needle Safety Syringes play in the developing healthcare landscape. These syringes’ revolutionary design includes an instantaneous needle retraction mechanism that activates when the plunger handle is fully depressed.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15450

Major technological developments related to needles and syringes, such as the introduction of retractable needle safety syringes, lubrication technology and needle-stick safety-equipped devices, have increased the demand for retractable needle safety syringes in the market.

In addition to this, development of various safety devices, such as a passive needle guard with an advanced retractable needle system and plastic shield is largely addressing the issue of needle-stick injuries. Thus, technological advancement will continue to play a key role in spurring growth of the Global Retractable Needle Safety Syringes Industry.

Furthermore, organizations and manufacturers with advanced procurement functions have the opportunity to grow and expand their business to purchasers and traders. Together they work to develop innovative products to boost revenues and profits for both parties. They are using different key strategies, such as new product launches, expansion, and collaborations, among others to expand their footprint.

For instance, in June 2021, the space Medtech start-up ResearchSat partnered with the subsidiary of Numedico Technologies Pty Ltd. (Numedico Science Pty Ltd.), to work together for developing innovative therapies and drugs delivery based systems.

Key Takeaways from Global Retractable Needle Safety Syringes Industry Study

  • By product, manual retractable safety syringes are expected to hold around 1% market value share by the end of 2032.
  • By application, intravenous segment holds a market share value of around 0%.
  • By end-user, hospitals segment accounted for the highest market share value of 7% in 2021.
  • North America accounted for around 4% revenue share of the Global Retractable Needle Safety Syringes Industry in 2021.
  • The retractable needle safety syringes market in Germany is set to expand at 1% CAGR during the forecast period.
  • Demand for retractable needle safety syringes in China to increase at a CAGR of 2% over the next ten years.

Understanding the assumptions of the study. Ask Analyst
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15450

 “With increasing advancement in retractable needle safety syringes and surge in needle stick injury cases, growth in the Global Retractable Needle Safety Syringes Industry is on the cards,” as per the Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Who is Winning?

Acquisition among the companies or brands is the key strategy of retractable needle safety syringe manufacturers such as Becton, Dickinson and Company, Cardinal Health, and Nipro Corporation to grow their presence in the market and compete with other competitors during the coming years. Following are a few examples of acquisitions made by them to be at the top position:

  • In November 2020, BD acquired the medical business assets of CUBEX LLC, broadening its automated dispensing portfolio across the care continuum.
  • In January 2019, Cardinal Health announced the acquisition of Mirixa Corporation, a leading organization in developing solutions for medication therapy management.
  • In February 2021, Terumo Corporation announced the acquisition of Health Outcomes Sciences, Inc.

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2012 to 2032. The Global Retractable Needle Safety Syringes Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on retractable needle safety syringes market segment based on Product – (Manual Retractable Safety Syringe and Auto-retractable Safety Syringe), By Application (Subcutaneous, Intramuscular, and Intravenous) By End User – (Hospitals, Clinics, Ambulatory Surgical Centres and Others), By Distribution Channel (Direct to Customer, Retail (Retail Pharmacies and Drug Stores) and Online Pharmacies) across seven major regions.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15450

Global Retractable Needle Safety Syringes Industry Key Players:

  • Axel Bio Corporation, Inc
  • Becton, Dickinson and Company
  • Numedico
  • Lifelong Group
  • DMC Medical Ltd.
  • Retractable Technologies, Inc.
  • Smiths Medical
  • Sol-Millennium Medical Group
  • UltiMed, Inc. (Ulticare)
  • Revolutions Medical Corporation
  • Medicine (HMC Group)
  • Haiou Medical
  • Mediprim
  • Cardinal Health
  • Medline Industries
  • Duopross Meditech Corp.
  • Nipro Corporation
  • Terumo Corporation

Key Market Segments Covered in Global Retractable Needle Safety Syringes Industry Research

By Product:

  • Manual Retractable Safety Syringe
  • Auto-retractable Safety Syringe

By Application:

  • Subcutaneous
  • Intramuscular
  • Intravenous

By End-User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

By Distribution Channel:

  • Direct to Customer
  • Retail
    • Retail Pharmacies
    • Drug Stores
  • Online Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Atherosclerosis Industry Expects to Reach US$ 59,514.3 Million by 2033, Growing at a Consistent 2.8% CAGR | FMI Report

The Global Atherosclerosis Industry is expected to be valued at US$ 59,514.3 million by 2033, indicating a strong Compound Annual Growth Rate (CAGR) of 2.8% from 2023 to 2033. This indicates that the industry is poised for profound change. By 2023, the market is expected to be worth US$ 45,165.6 million.

Plaque buildup in arteries is known as atherosclerosis, and it has become a focus of intense medical study and innovation. One major factor propelling the market for atherosclerosis growth is the rising incidence of cardiovascular diseases. This predicted increase highlights the pressing need for cutting-edge approaches to reduce the burden of cardiovascular disease worldwide.

The Global Atherosclerosis Industry faces a paradigm shift as it addresses the challenges posed by the accumulation of plaque, consisting of low-density lipoprotein (LDL cholesterol) and macrophage white blood cells. This phenomenon often leads to the cells becoming trapped at the affected site, resulting in the formation of arterial plaque over time.

Request for a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-2523

The plaque obstructs the corridor, upsetting the stream of blood around the body. This possibly causes blood clusters that can bring about existence undermining conditions, for example, heart assault, stroke and other cardiovascular ailments. Besides aging, aspects that upsurge the risk of atherosclerosis include: High blood pressure, high cholesterol, diabetes, obesity, smoking or other tobacco use, family history of early heart disease, lack of exercise and an unhealthy diet.

Global Atherosclerosis Industry: Drivers and Restraints

Growing incidence of heart attacks due to atherosclerosis or coronary heart disease is expected to increase demand for atherosclerosis treatment products. The rise in the aging population is expected to propel demand over the forecast period.

As per CDC (Centers for Disease Control and Prevention), coronary illness accounts for around 610,000 deaths per year in the United States- roughly being responsible for 1 of every 4 deaths reported. Coronary illness is the most widely recognized kind of coronary illness, killing more than 370,000 individuals every year. This increase in the baby boomer population is expected to add to the patient pool of atherosclerosis and thus in turn increase demand for treatment over the forecast period.

The development in atherosclerosis market is determined by expanded prevalence, obesity, sedentary lifestyle, hypertension, dyslipidemia, an especially decrease in high thickness cholesterol (HDL-C), and elevated cholesterol slim down. Medications to treat Atherosclerosis incorporates statins, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers (BB), antiplatelets, calcium channel blockers (CCBs) and nitrates.

With the dispatch of first-in-class pipeline molecules, for example, Yosprala (headache medicine and omeprazole), Praluent (alirocumab), Dalcetrapib (RG1658), Vorapaxar (SCH 530348), Canakinumab (ACZ885), Varespladib (A 002), Aliskiren, Generx, Xarelto (rivaroxaban), Anacetrapib (MK0859), and others are relied upon to get propelled in the forecasting period. New contestants in the atherosclerosis market have indicated expanded adequacy and security profiles along with the reduction of CHD risk factors.

Request Customization 
https://www.futuremarketinsights.com/customization-available/rep-gb-2523

Atherosclerosis or coronary artery disease showcase likewise has two different methods of treatment, which are coronary artery bypass grafting (CABG) and angioplasty. The CAD death rate is very high contrasted with different maladies because of coronary events connected with CAD, including myocardial infections (MI), angina and strokes.

In this way, the counteractive action of such events remains an undiscovered region of research and development for pharmaceutical organizations to bring novel medications into the market. However, the absence of definitive treatment, side effects and limited efficacy of the drugs available in the market and dependency in symptom based treatment in several cases is expected to hamper revenue growth of the atherosclerosis market over the forecast period.

Global Atherosclerosis Industry: Overview

The global market for atherosclerosis is expected to witness robust growth owing to increasing incidence rate of the heart problems coupled with new treatment (branded and generic) approach.

Atherosclerosis Industry: Region–wise Outlook

Globally the atherosclerosis market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America and Western Europe are expected to be the leading markets in the global atherosclerosis market.

Rising treatment options among the aging population, prescription rates, and the maturing worldwide population are additionally considered vital drivers for this market. High awareness and easy available diagnostic tests are expected to boost demand for RSV infection treatment products in these regions. Japan and APEJ are expected to follow next in terms of demand for the treatment of atherosclerosis market.

Eastern Europe, Latin America, and MEA markets are also expected to witness above average growth over the forecast period. The absence of population-based studies in developing countries is a major challenge in the assessment of RSV-related infections in these countries.

Global Atherosclerosis Industry: Participants

  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • Isis Pharmaceuticals, Inc.
  • Anthera Pharmaceuticals
  • Novartis AG
  • Sanofi
  • Johnson and Johnson
  • Bayer AG

Ask An Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-2523

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube